Trelegy ellipta 200-62.5-25 60S
Ended Awarded Last action
- Contract number
- SPE2DR26F3TWR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,971
Award facts
- Contract value 100% obligated
- $13,971.15 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,971.15 to AmerisourceBergen Drug Corp on January 16, 2026, for the supply of Trelegy Ellipta 200-62.5-25, a combination respiratory medication delivered in a 60-dose inhaler. This competitively awarded, firm fixed-price delivery order is not designated as a set-aside contract and is scheduled for ultimate completion by January 20, 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate operations. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (formerly doing business as AmerisourceBergen), a major pharmaceutical distributor and healthcare solutions provider serving federal medical procurement needs.
This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. That prime contract vehicle enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains. The arrangement supports critical federal healthcare initiatives, including services to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems requiring reliable pharmaceutical supply chains.
Quick answers
Who was awarded contract SPE2DR26F3TWR?
SPE2DR26F3TWR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26F3TWR worth?
The government has obligated $13,971 on SPE2DR26F3TWR.
Is contract SPE2DR26F3TWR an order under another contract?
Yes. SPE2DR26F3TWR is a delivery order under SPE2DR25D2104, an indefinite delivery contract.
Was contract SPE2DR26F3TWR competed?
The extent of competition for SPE2DR26F3TWR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award